Roseman University of Health Sciences, South Jordan, Utah.
Global Health Economics and Outcomes Research, Teva Pharmaceuticals, Frazer, Pennsylvania.
Ann Allergy Asthma Immunol. 2018 Dec;121(6):680-691.e1. doi: 10.1016/j.anai.2018.10.016. Epub 2018 Oct 22.
A new generation of digital health technologies (DHT) offers the opportunity to improve adherence and asthma control. Recent literature was reviewed to summarize the use of technological aids and evaluate their impact on health outcomes in patients with asthma.
PubMed and Embase were searched to identify articles published over the past 5 years (2013 to 2017).
All records were judged for eligibility by 2 independent reviewers; 28 articles met the inclusion criteria.
Interactive websites were the most frequently evaluated type of DHT (50% of all studies), followed by mobile apps in adult patient cohorts. Relatively few studies assessed electronic monitoring devices, phone calls, or text messaging. Among the 16 studies that focused on children, most interventions that used interactive websites (n = 8) showed at least some benefit, although results varied based on the specific outcome. Twelve studies focused on adults, with interventions using interactive websites (n = 6) reporting results that were generally less consistent compared with the pediatric studies. The 6 studies that assessed mobile apps with adult patients reported consistent benefits across a range of outcomes, including medication adherence and asthma control.
Most interventions reported at least some benefit, although results varied based on the specific outcome. Overall, technology that included more interactive features, such as website-based daily diary entries and apps that provided real-time feedback, was associated with increased asthma control, as was the case for multidimensional interventions that combined the use of several complementary types of DHT.
新一代数字健康技术(DHT)提供了改善依从性和哮喘控制的机会。回顾了最近的文献,总结了技术辅助工具的使用情况,并评估了它们对哮喘患者健康结果的影响。
在过去 5 年(2013 年至 2017 年)中,在 PubMed 和 Embase 上搜索了发表的文章。
由 2 名独立评审员对所有记录进行了资格判断;28 篇文章符合纳入标准。
互动网站是评估最多的 DHT 类型(所有研究的 50%),其次是成人患者队列中的移动应用程序。相对较少的研究评估了电子监测设备、电话或短信。在关注儿童的 16 项研究中,大多数使用互动网站的干预措施(n=8)显示出至少有一些益处,尽管结果因具体结果而异。12 项研究关注成年人,使用互动网站的干预措施(n=6)报告的结果与儿科研究相比通常不太一致。对使用移动应用程序的 6 项成人研究报告了一系列结果的一致益处,包括药物依从性和哮喘控制。
大多数干预措施报告至少有一些益处,尽管结果因具体结果而异。总体而言,包括更具交互性功能的技术,如基于网站的每日日记条目和提供实时反馈的应用程序,与增加哮喘控制相关,这与结合使用几种互补类型的 DHT 的多维干预措施的情况一样。